Receptor specificity defines algogenic properties of propofol and fospropofol

Anesthesia and Analgesia

Volumn 115, Issue 4, 2012, Pages 837-840

  Patwardhan, Amol ^a   Edelmayer, Rebecca ^a   Annabi, Emil ^a   Price, Theodore ^a   Malan, Phil ^a   Dussor, Gregory ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSPROPOFOL; PROPOFOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CELL MEMBRANE DEPOLARIZATION; DRUG RECEPTOR BINDING; GENERAL ANESTHESIA; INJECTION SITE PAIN; MALE; NERVE CELL; NONHUMAN; PAIN RECEPTOR; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIGEMINUS GANGLION;

ANIMALS; CELLS, CULTURED; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; MALE; PAIN; PRODRUGS; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; TRPC CATION CHANNELS;

EID: 84866911470     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318258b9db     Document Type: Article

References (15)

1. Picard P, Tramer MR. Prevention of pain on injection with propofol: A quantitative systematic review. Anesth Analg 2000;90:963-9
2. Paul M, Dueck M, Kampe S, Fruendt H, Kasper SM. Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil. Anaesthesia 2003;58:1055-62
3. Moore GD, Walker AM, MacLaren R. Fospropofol: A new sedative-hypnotic agent for monitored anesthesia care. Ann Pharmacother 2009;43:1802-8
4. Scott RP, Saunders DA, Norman J. Propofol: Clinical strategies for preventing the pain of injection. Anaesthesia 1988;43:492-4
5. Matta JA, Cornett PM, Miyares RL, Abe K, Sahibzada N, Ahern GP. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci USA 2008;105:8784-9
6. Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: Targeting pain at the source. Nat Rev Drug Discov 2009;8:55-68
7. Story GM, Gereau RWt. Numbing the senses: Role of TRPA1 in mechanical and cold sensation. Neuron 2006;50:177-80
8. Macpherson LJ, Dubin AE, Evans MJ, Marr F, Schultz PG, Cravatt BF, Patapoutian A. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007;445:541-5
9. Cavazzuti M, Porro CA, Barbieri A, Galetti A. Brain and spinal cord metabolic activity during propofol anaesthesia. Br J Anaesth 1991;66:490-5
10. Fischer MJ, Leffler A, Niedermirtl F, Kistner K, Eberhardt M, Reeh PW, Nau C. The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem 2010;285:34781-92
11. Zhang H, Wickley PJ, Sinha S, Bratz IN, Damron DS. Propofol restores transient receptor potential vanilloid receptor subtype-1 sensitivity via activation of transient receptor potential ankyrin receptor subtype-1 in sensory neurons. Anesthesiology 2011;114:1169-79
12. Li X, Zhang Y, Fan Y, Zhou Y, Wang X, Fan C, Liu Y, Zhang Q. Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol. Nanoscale Res Lett 2011;6:275
13. Cohen LB. Clinical trial: A dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 2008;27:597-608
14. Dubey PK, Kumar A. Vascular complication following lipid free propofol injection. J Postgrad Med 2005;51:73-4
15. Tokumine J, Sugahara K, Tomori T, Nagasawa Y, Takaesu Y, Hokama A. Tissue necrosis caused by extravasated propofol. J Anesth 2002;16:358-9